1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Clinical Supply Management
  6.  » Industry Perspective: Defining the Optimal Clinical Supply Strategy for Cell/Gene Therapy Studies

Industry Perspective: Defining the Optimal Supply Strategy for Cell/Gene Therapy Studies

Summary: Cell and gene therapies hold the promise to offer new hope and novel therapeutic avenues for individuals facing serious illnesses and medical conditions, but successfully bringing these therapies through the clinical trial process introduces levels of supply chain risk, complexity and specialized requirements which are not yet fully understood. This webinar focuses on taking a closer look at the unique clinical supply challenges and needs associated with cell and gene therapy studies.

Click here to view the webinar